XERS Xeris Biopharma Holdings Inc
10,227
$1.78
$0.10
(5.32%)
| Watchers | 10,227 |
| 52-Wk Low | $1.46 |
| 52-Wk High | $3.26 |
| Market Cap | $278.72M |
| Volume | 1.64M |
| 52-Wk High | $3.26 |
| 52-Wk Low | $1.46 |
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent EventsBusiness Wire • 1 day ago
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of...
Share to Feed
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients lives by developing and commercializing innovative products across a range...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of...
Biopharmaceutical Innovator Sees Significant Increases in Product Sales and Cash FlowRelated Stocks: XERS...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients lives by developing and commercializing innovative products across a range...
This indicator may be signaling that XERS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This is a Bearish indicator signaling XERS's price could decline from here. Traders may explore shorting the stock or put options...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients lives by developing and commercializing innovative products across a range...